Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > So how much of this...
View:
Post by Forestview on Mar 29, 2021 12:52pm

So how much of this...

Is overall market.  My watch list is mainly red today, so I'm wondering if we aren't getting people biting due to overall macro economic factors.  But, I'm really nervous.  This was a big announcement, one that should have driven the share up by double digits.  And this chicken vs. egg thing of going to Nasdaq - can't go to Nasdaq without a high SP, but can't get a high SP because of the exchange we are on, is very vexing.

I know I need to be patient, but this stock really really tests one's patience.
Comment by Amigo11 on Mar 29, 2021 1:24pm
So overall market is a factor but ......this is another vale building credit in favour of Antibe.Coming 1 business day after the 19-1 vote against the Pfizer Lilly entrant is possibly also a negative showing that even after 15 years and 41 trials and the names Pfizer /Lilly cant get across the finish line then WTF.Anyway,I firmly believe I have latched on to a $15(us) sharevalue.I ll ride a triple ...more  
Comment by CoffeeBeans on Mar 29, 2021 2:02pm
It's not the overall market. December 31, 2019 the stock was trading at $.45 on the venture exchange. It's trading at less than $.50 a share on the Toronto Stock exchange and all markets are up substantially higher over the last 15 months. The 2017 and I'm hoping they sell everything and I will take $10 a share in a heartbeat. For those longs I'm sure you remember that this was ...more  
Comment by Straylight on Mar 29, 2021 2:20pm
I mean based on the big drops today (and in recently past days) and the wall at $5.04, am I crazy to think I am seeing a pattern where it seems people are trying to keep this right around $5? Is there a reason for it? I mean if you wanted to buy out a company certainly keeping their share price as low as possible would benefit you in negotiations. Short traders trying to make a buck?  Just ...more  
Comment by WalkOverTheStrt on Mar 29, 2021 10:50pm
BoD isn't going to take $10 USD or anything less than a few billion... there are not buyers in the market of late and esp on this exchange. Money is rotating and will be back into biotechs by late summer / fall.. have patience. This stock is hard to hold but the potential payout $USD billions will be worth it